Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Attitudes and Experiences of Patients Engaged in Buprenorphine Treatment During the COVID-19 Pandemic

NCT05121428 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT05121428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05121428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Attitudes and Experiences of Patients Engaged in Buprenorphine Treatment During the COVID-19 Pandemic
Lead sponsor
Cambridge Health Alliance
Phase
Observational
Overall status
Suspended
Start date
November 20, 2021
Completion date
March 20, 2027
Enrollment
817 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acceptability of health care, opioid-related disorders, opioid-use disorder